It will be important to investigate whether Oligo-Fucoidan impacts the classical activation of M1 macrophages and/or the inhibition of M2 macrophages via inhibiting CCL2 and IL-6 signaling, which modulate anti-inflammation, tumor immunity and tissue remodeling (angiogenesis and metastasis). The gene discussed is CCL2; the disease is neoplasm.